G12A (p.Gly12Ala) variant of KRAS (GTPase KRas)
G12A (p.Gly12Ala) in KRAS (GTPase KRas) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of KRAS-related disorder; Gastric cancer; Familial cancer of breast. The available variant effect predictions contribute to a CATVariant prioritization score of 0.77 / 1. The record also includes population frequency data, experimental measurements, published literature, and structural context.
G12A (p.Gly12Ala) variant details
- p.Gly12Ala
- rs121913529
- ClinGen CA135567
- NCI-TCGA Cosmic COSV5549
- Pathogenic/Likely pathogenic
- KRAS-related disorder; Gastric cancer; Familial cancer of breast
- Missense
- Variant Prioritization Score for Impact Estimate 0.766
- REVEL 0.84
- ESM-1b 1.00
- AlphaMissense 0.96
- MetaLR 0.57
- MetaSVM 0.22
- CADD 26.20
- ClinVar: Pathogenic/Likely pathogenic (KRAS-related disorder; Gastric cancer; Familial cancer of breast)
- EBI: Pathogenic (in colorectal cancer samples)
- UniProt: Pathogenic (in colorectal cancer samples)
- Most common in the Non-Finnish European population (allele frequency 1.8e-06)
- Structural context available
- KRAS activity — DMSO (standardized): score 8.7
- Cited in: The consensus coding sequences of human breast and colorectal cancers. (PMID 16959974)
- Cited in: KRAS A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases. (PMID 34820593)